Clinical Trial Update: Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating candesartan versus placebo to prevent trastuzumab-associated cardiotoxicity in breast cancer, with the study status listed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Candesartan (candesartan)

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED